Literature DB >> 18059017

Mycoplasma infection transforms normal lung cells and induces bone morphogenetic protein 2 expression by post-transcriptional mechanisms.

Shan Jiang1, Shimin Zhang, John Langenfeld, Shyh-Ching Lo, Melissa B Rogers.   

Abstract

Bone morphogenetic protein 2 (BMP2) is an essential growth factor and morphogen, whose pattern and level of expression profoundly influences development and physiology. We present the novel finding that mycoplasma infection induces BMP2 RNA production in six cell lines of diverse types (mesenchymal, epithelial, and myeloid). Mycoplasma infection triggered the expression of mature secreted BMP2 protein in BEAS-2B cells (immortalized human bronchial epithelial cells), which normally do not express BMP2, and further increased BMP2 production in A549 cells (lung adenocarcinoma cells). Indeed, mycoplasma is as strong an experimental inducer as inflammatory cytokines and retinoic acid. Second, we showed that post-transcriptional mechanisms including regulation of RNA stability, rather than transcriptional mechanisms, contributed to the increased BMP2 expression in mycoplasma-infected cells. Furthermore, a novel G-rich oligonucleotide, AS1411 that binds the post-transcriptional regulator nucleolin induced BMP2 exclusively in infected cells. Finally, BMP2 stimulated proliferation in BEAS-2B cells transformed by chronic mycoplasma infection, as demonstrated by treatment with Noggin, a BMP2 antagonist. These findings have important implications regarding the effects of mycoplasma on BMP2-regulated processes, including cell proliferation, differentiation, and apoptosis. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18059017     DOI: 10.1002/jcb.21647

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  28 in total

1.  Mycoplasma hyorhinis reduces sensitivity of human lung carcinoma cells to Nutlin-3 and promotes their malignant phenotype.

Authors:  Uljana A Boyarskikh; Alexandra S Shadrina; Mariya A Smetanina; Yakov A Tsepilov; Igor P Oscorbin; Vadim V Kozlov; Alexander E Kel; Maxim L Filipenko
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-08       Impact factor: 4.553

Review 2.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

3.  Construction of a eukaryotic expression vector pEGFP-C1-BMP-2 and its effect on cell migration.

Authors:  Xiao-ying Wang; Zhong-hua Chen; Ru-yi Zhang; Sen-quan Liu; Zhu Mei; Ying-ying Yu; Xiong Zhang; Qiang Xia; Yue-min Ding
Journal:  J Zhejiang Univ Sci B       Date:  2012-05       Impact factor: 3.066

4.  An autonomous BMP2 regulatory element in mesenchymal cells.

Authors:  Boudewijn P T Kruithof; David T Fritz; Yijun Liu; Diane E Garsetti; David B Frank; Steven K Pregizer; Vinciane Gaussin; Douglas P Mortlock; Melissa B Rogers
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

5.  Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro.

Authors:  Craig Gedye; Tracy Cardwell; Nektaria Dimopoulos; Bee Shin Tan; Heather Jackson; Suzanne Svobodová; Matthew Anaka; Andreas Behren; Christopher Maher; Oliver Hofmann; Winston Hide; Otavia Caballero; Ian D Davis; Jonathan Cebon
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

6.  Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells.

Authors:  Anastasios Fotinos; Narayani Nagarajan; Adriano S Martins; David T Fritz; Diane Garsetti; Annette T Lee; Charles C Hong; Melissa B Rogers
Journal:  Anticancer Res       Date:  2014-05       Impact factor: 2.480

Review 7.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

8.  Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy-histomorphometric and immunohistochemical analysis.

Authors:  Miguel Luciano Silva; Leandro Tasso; Alan Arrieira Azambuja; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Vinicius Duval da Silva; Karen Cherubini
Journal:  Clin Oral Investig       Date:  2016-03-09       Impact factor: 3.573

9.  Differences in fat and muscle mass associated with a functional human polymorphism in a post-transcriptional BMP2 gene regulatory element.

Authors:  Joseph M Devaney; Laura L Tosi; David T Fritz; Heather A Gordish-Dressman; Shan Jiang; Funda E Orkunoglu-Suer; Andrew H Gordon; Brennan T Harmon; Paul D Thompson; Priscilla M Clarkson; Theodore J Angelopoulos; Paul M Gordon; Niall M Moyna; Linda S Pescatello; Paul S Visich; Robert F Zoeller; Cinzia Brandoli; Eric P Hoffman; Melissa B Rogers
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

10.  Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation.

Authors:  D Y Logunov; D V Scheblyakov; O V Zubkova; M M Shmarov; I V Rakovskaya; K V Gurova; N D Tararova; L G Burdelya; B S Naroditsky; A L Ginzburg; A V Gudkov
Journal:  Oncogene       Date:  2008-04-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.